639 related articles for article (PubMed ID: 15759279)
81. ATRA enhances bystander effect of suicide gene therapy in the treatment of prostate cancer.
Chen W; Yan C; Hou J; Pu J; Ouyang J; Wen D
Urol Oncol; 2008; 26(4):397-405. PubMed ID: 18367126
[TBL] [Abstract][Full Text] [Related]
82. [*OPCML gene transferred by recombinant lentiviruses in vitro and its inhibition to ovarian cancer cells].
Yao DS; Li L; Garson K; Vanderhyden BC
Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):333-8. PubMed ID: 16762191
[TBL] [Abstract][Full Text] [Related]
83. The combination of HSV-tk and endostatin gene therapy eradicates orthotopic human renal cell carcinomas in nude mice.
Pulkkanen KJ; Laukkanen JM; Fuxe J; Kettunen MI; Rehn M; Kannasto JM; Parkkinen JJ; Kauppinen RA; Pettersson RF; Yla-Herttuala S
Cancer Gene Ther; 2002 Nov; 9(11):908-16. PubMed ID: 12386829
[TBL] [Abstract][Full Text] [Related]
84. Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy.
Lambright ES; Amin K; Wiewrodt R; Force SD; Lanuti M; Propert KJ; Litzky L; Kaiser LR; Albelda SM
Gene Ther; 2001 Jun; 8(12):946-53. PubMed ID: 11426335
[TBL] [Abstract][Full Text] [Related]
85. Gene-directed enzyme prodrug therapy with carboxylesterase enhances the anticancer efficacy of the conditionally replicating adenovirus AdDelta24.
Oosterhoff D; Pinedo HM; Witlox MA; Carette JE; Gerritsen WR; van Beusechem VW
Gene Ther; 2005 Jun; 12(12):1011-8. PubMed ID: 15729367
[TBL] [Abstract][Full Text] [Related]
86. Combination gene therapy using multidrug resistance (MDR1) gene shRNA and herpes simplex virus-thymidine kinase.
Park SY; Lee W; Lee J; Kim IS
Cancer Lett; 2008 Mar; 261(2):205-14. PubMed ID: 18096314
[TBL] [Abstract][Full Text] [Related]
87. Functional expression of thymidine kinase in human leukaemic and colorectal cells, delivered as EGFP fusion protein by herpesvirus saimiri-based vector.
Hoggarth JH; Jones E; Ensser A; Meredith DM
Cancer Gene Ther; 2004 Sep; 11(9):613-24. PubMed ID: 15243631
[TBL] [Abstract][Full Text] [Related]
88. Rat adenocarcinoma cell line infected with an adenovirus carrying a novel herpes-simplex virus-thymidine kinase suicide gene construct dies by apoptosis upon treatment with ganciclovir.
Chu QD; Sun L; Li J; Byrnes K; Chervenak D; DeBenedetti A; Mathis JM; Li BD
J Surg Res; 2007 Nov; 143(1):189-94. PubMed ID: 17950092
[TBL] [Abstract][Full Text] [Related]
89. Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered P27-VP22 fusion protein.
Zavaglia D; Favrot MC; Eymin B; Tenaud C; Coll JL
Gene Ther; 2003 Feb; 10(4):314-25. PubMed ID: 12595890
[TBL] [Abstract][Full Text] [Related]
90. Persistent adenovirus-mediated thymidine kinase gene expression in ovarian cancer cells increases cell killing efficacy over time.
Kieback DG; Delvoux B; Romano A; Ollig S; Fischer DC
Anticancer Res; 2008; 28(5A):2569-75. PubMed ID: 19035280
[TBL] [Abstract][Full Text] [Related]
91. The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella zoster and Herpes simplex viral thymidine kinases in suicide gene therapy.
Grignet-Debrus C; Cool V; Baudson N; Velu T; Calberg-Bacq CM
Cancer Gene Ther; 2000 Nov; 7(11):1456-68. PubMed ID: 11129288
[TBL] [Abstract][Full Text] [Related]
92. HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer.
Lifang Y; Min T; Midan A; Ya C
J Exp Clin Cancer Res; 2008 Sep; 27(1):42. PubMed ID: 18811956
[TBL] [Abstract][Full Text] [Related]
93. Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer.
Isomoto H; Ohtsuru A; Braiden V; Iwamatsu M; Miki F; Kawashita Y; Mizuta Y; Kaneda Y; Kohno S; Yamashita S
Oncol Rep; 2006 Mar; 15(3):629-35. PubMed ID: 16465423
[TBL] [Abstract][Full Text] [Related]
94. Killing effect of coexpressing cytosine deaminase and thymidine kinase on rat vascular smooth muscle cells.
Cao HQ; Meng XM; Liu DQ; Zhao XW; Ding JF
Chin Med J (Engl); 2004 Oct; 117(10):1464-70. PubMed ID: 15498366
[TBL] [Abstract][Full Text] [Related]
95. Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma.
Tsuchiyama T; Kaneko S; Nakamoto Y; Sakai Y; Honda M; Mukaida N; Kobayashi K
Cancer Gene Ther; 2003 Apr; 10(4):260-9. PubMed ID: 12679798
[TBL] [Abstract][Full Text] [Related]
96. The effect of HSV-tk/GCV on hepatic specific damage driven by murine ALB promoter/enhancer.
Zhang Y; Huang SZ; Zeng YT
Yi Chuan Xue Bao; 2004 Oct; 31(10):1053-60. PubMed ID: 15552038
[TBL] [Abstract][Full Text] [Related]
97. Inhibition of glioma cells in vitro and in vivo using a recombinant adenoviral vector containing an astrocyte-specific promoter.
Vandier D; Rixe O; Besnard F; Kim M; Rikiyama T; Goldsmith M; Brenner M; Gouyette A; Cowan KH
Cancer Gene Ther; 2000 Aug; 7(8):1120-6. PubMed ID: 10975672
[TBL] [Abstract][Full Text] [Related]
98. [Vesicular stomatitis virus G-protein retrovector mediated a herpes simplex virus thymidine kinase gene transduction and expression in the human retinal pigment epithelial cells].
Wang F; Wang HW; Lu DR; Xue JL; Zhang X
Zhonghua Yan Ke Za Zhi; 2003 Apr; 39(4):201-5. PubMed ID: 12882696
[TBL] [Abstract][Full Text] [Related]
99. [Experimental study on lung carcinoma-targeted suicide gene therapy induced by irradiation].
Wang WD; Chen ZT; Li DZ; Duan YZ; Cao ZH
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):84-7. PubMed ID: 12783658
[TBL] [Abstract][Full Text] [Related]
100. Therapy of peritoneal carcinomatosis from colon cancer with oncolytic adenoviruses.
Wildner O; Morris JC
J Gene Med; 2000; 2(5):353-60. PubMed ID: 11045429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
